SGC and collaborating institutions will lead development of openly distributed tools to test the efficacy of Alzheimer’s therapies and rapidly share results

The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a grant expected to total $37.5 million over five years to establish the Open-AD Drug Discovery Center. Led by Emory University, the Center includes investigators at Sage Bionetworks, Structural Genomics Consortium (SGC), Stanford University, Oxford University, and University of North Carolina.

SGC's director, Aled Edwards, pens an op-ed in The Globe and Mail on stimulating innovation in Canada with open science. Full article here. 

In collaboration with the SGC and the Genetic Alliance, the UNC Catalyst at the University of North Carolina will give researchers the tools and knowledge to tackle rare and orphaned diseases. The initiative was launched with a $2 million grant from the Eshelman Institute for Innovation. For the full news release, please read here.